-
-
-
-
-
-
-
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $510 at Leerink Partners
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $469 at Citi
-
-
-
-
-
-
-
Madrigal Pharma (MDGL) Tops Q3 EPS by $1.84, Beats on Revenue
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
-
1,231,828 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


